Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Jun;75(Suppl 2):ii43–ii50. doi: 10.1136/jnnp.2004.040378

PARANEOPLASTIC SYNDROMES: WHEN TO SUSPECT, HOW TO CONFIRM, AND HOW TO MANAGE

J Rees
PMCID: PMC1765657  PMID: 15146039

Full Text

The Full Text of this article is available as a PDF (176.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Croft P. B., Wilkinson M. The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain. 1965 Sep;88(3):427–434. doi: 10.1093/brain/88.3.427. [DOI] [PubMed] [Google Scholar]
  2. Darnell Robert B., Posner Jerome B. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003 Oct 16;349(16):1543–1554. doi: 10.1056/NEJMra023009. [DOI] [PubMed] [Google Scholar]
  3. Elrington G. M., Murray N. M., Spiro S. G., Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):764–767. doi: 10.1136/jnnp.54.9.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Graus F., Dalmou J., Reñ R., Tora M., Malats N., Verschuuren J. J., Cardenal F., Viñolas N., Garcia del Muro J., Vadell C. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol. 1997 Aug;15(8):2866–2872. doi: 10.1200/JCO.1997.15.8.2866. [DOI] [PubMed] [Google Scholar]
  5. Graus F., Keime-Guibert F., Reñe R., Benyahia B., Ribalta T., Ascaso C., Escaramis G., Delattre J. Y. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001 Jun;124(Pt 6):1138–1148. doi: 10.1093/brain/124.6.1138. [DOI] [PubMed] [Google Scholar]
  6. Newsom-Davis John. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Semin Neurol. 2003 Jun;23(2):191–198. doi: 10.1055/s-2003-41135. [DOI] [PubMed] [Google Scholar]
  7. Rees J. H., Hain S. F., Johnson M. R., Hughes R. A., Costa D. C., Ell P. J., Keir G., Rudge P. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain. 2001 Nov;124(Pt 11):2223–2231. doi: 10.1093/brain/124.11.2223. [DOI] [PubMed] [Google Scholar]
  8. Rowland L. P. Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis. Ann Neurol. 1997 Jun;41(6):703–705. doi: 10.1002/ana.410410605. [DOI] [PubMed] [Google Scholar]
  9. Shams'ili Setareh, Grefkens Joost, de Leeuw Bertie, van den Bent Martin, Hooijkaas Herbert, van der Holt Bronno, Vecht Charles, Sillevis Smitt Peter. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003 Jun;126(Pt 6):1409–1418. doi: 10.1093/brain/awg133. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES